Tenon Medical Announces Issuance of Three Notices of Allowance for Patent Applications from the USPTO

ACCESSWIRE09-20

Tenon Now Holds 9 Granted Patents and 26 Pending Applications for the Catamaran® SI Joint Fusion System Worldwide LOS GATOS, CA / ACCESSWIRE / September 19, 2024 / Tenon Medical, Inc. (NASDAQ:TNON) ("...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2468687786?lang=en_US&edition=fundamental","thumbnail":"https://s.yimg.com/uu/api/res/1.2/0zRmSoFnhPFh7_rj99_lZg--~B/aD00MDA7dz00MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/accesswire.ca/15428fabdb6c2bb0cc631cc63aafe0db","is_english":true,"pubTime":"2024-09-20 04:05","share_image_url":"https://static.laohu8.com/5f26f4a48f9cb3e29be4d71d3ba8c038","id":"2468687786","market":"us","top_or_hot":-1,"title":"Tenon Medical Announces Issuance of Three Notices of Allowance for Patent Applications from the USPTO","media":"ACCESSWIRE","content":"<div>\n<p>Tenon Now Holds 9 Granted Patents and 26 Pending Applications for the Catamaran® SI Joint Fusion System Worldwide\nLOS GATOS, CA / ACCESSWIRE / September 19, 2024 / Tenon Medical, Inc. (NASDAQ:TNON) (\"...</p>\n\n<a href=\"https://finance.yahoo.com/news/tenon-medical-announces-issuance-three-200500676.html\">Source Link</a>\n\n</div>\n","source":"yahoofinance","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Tenon Medical Announces Issuance of Three Notices of Allowance for Patent Applications from the USPTO</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nTenon Medical Announces Issuance of Three Notices of Allowance for Patent Applications from the USPTO\n</h2>\n\n<h4 class=\"meta\">\n\n\n2024-09-20 04:05 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://finance.yahoo.com/news/tenon-medical-announces-issuance-three-200500676.html><strong>ACCESSWIRE</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Tenon Now Holds 9 Granted Patents and 26 Pending Applications for the Catamaran® SI Joint Fusion System Worldwide\nLOS GATOS, CA / ACCESSWIRE / September 19, 2024 / Tenon Medical, Inc. (NASDAQ:TNON) (\"...</p>\n\n<a href=\"https://finance.yahoo.com/news/tenon-medical-announces-issuance-three-200500676.html\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"TNON","symbol_name":"Tenon Medical, Inc.","start_time":0,"source_url":"https://finance.yahoo.com/news/tenon-medical-announces-issuance-three-200500676.html","article_id":"2468687786","we_media_id":null,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/0zRmSoFnhPFh7_rj99_lZg--~B/aD00MDA7dz00MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/accesswire.ca/15428fabdb6c2bb0cc631cc63aafe0db"],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2468687786","pubTimestamp":1726776300,"sourceInfo":{"source_id":"yahoofinance","name":"雅虎金融"},"weMediaInfo":null,"summary":"Tenon Now Holds 9 Granted Patents and 26 Pending Applications for the Catamaran SI Joint Fusion System Worldwide. LOS GATOS, CA / ACCESSWIRE / September 19, 2024 / Tenon Medical, Inc.  , a company transforming care for patients suffering from certain Sacroiliac Joint  disorders, today announced the United States Patent and Trademark Office  issued three  Notices of Allowance for U.S. Patent Application Numbers 17,469,132 and 17/468,811, both entitled \"Sacroiliac Joint Stabilization Prostheses\", and 18/612,032, entitled \"Systems, Apparatus and Methods for Stabilizing Sacroiliac Joints\". The U.S. patents based on the applications should thus issue within the next ninety  days.Tenon Medical, Inc., a medical device company formed in 2012, has developed The Catamaran SI Joint Fusion System that offers a novel, less invasive approach to the SI joint using a single, robust titanium implant. The system features the Catamaran Fixation Device which passes through both the axial and sagittal plan","collect":0,"end_time":0,"defaultTopTitle":"yahoo.com","property":[],"viewcount":null,"language":"en","relate_stocks":{"TNON":"Tenon Medical, Inc.","BK4082":"医疗保健设备","SIJ":"ProShares UltraShort Industrials","TNONW":"TENON MEDICAL INC"},"translate_title":"Tenon Medical宣布发布三份USPTO专利申请许可通知","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"SIJ":1,"TNON":1,"TNONW":0.9},"content_text":"Tenon Now Holds 9 Granted Patents and 26 Pending Applications for the Catamaran® SI Joint Fusion System Worldwide\nLOS GATOS, CA / ACCESSWIRE / September 19, 2024 / Tenon Medical, Inc. (NASDAQ:TNON) (\"Tenon\" or the \"Company\"), a company transforming care for patients suffering from certain Sacroiliac Joint (SIJ) disorders, today announced the United States Patent and Trademark Office (\"USPTO\") issued three (3) Notices of Allowance for U.S. Patent Application Numbers 17,469,132 and 17/468,811, both entitled \"Sacroiliac Joint Stabilization Prostheses\", and 18/612,032, entitled \"Systems, Apparatus and Methods for Stabilizing Sacroiliac Joints\". The U.S. patents based on the applications should thus issue within the next ninety (90) days.\nU.S. Pat. App. Nos. 17,469,132 and 17/468,811 are directed to SI joint prostheses that include unique drug delivery compositions that aid in bone growth about and within the prostheses when implanted in a SI joint. U.S. Pat. App. No. 18/612,032 is directed to SI joint prostheses with unique configurations to correct failed SI joint stabilization with alternative commercial SI joint implants without requiring removal of the failed implant.\nThe three (3) U.S. patents, when issued, will further enhance the Company's growing patent portfolio for its Catamaran® SI Joint implant system, which now comprises nine (9) issued U.S. and foreign (International) patents, and twenty-six (26) pending U.S. and foreign patent applications.\n\"A critical component of our growth strategy is pursuing and obtaining effective intellectual property protection for the key technology, processes and devices of our Catamaran® SI Joint Fusion System. As we advance our commercialization efforts, we are pleased to have reinforcement by the USPTO, which has again provided us with Notice of Allowances for these three new patents,\" said Richard Ginn, Co-Founder and Chief Technology Officer of Tenon Medical. \"As we continue to aggressively develop our intellectual property, we have added a number of new patents and patent applications, including the three (3) soon to be issued U.S. patents and three (3) recently filed U.S. patent applications. IP efforts such as these serve to further solidify our international patent portfolio, protect our technology platform, strengthen our competitive position in the industry, and underscore our commitment to innovation in advancing a less invasive approach to the SI joint.\"\nAbout Tenon Medical, Inc.\nTenon Medical, Inc., a medical device company formed in 2012, has developed The Catamaran SI Joint Fusion System that offers a novel, less invasive approach to the SI joint using a single, robust titanium implant. The system features the Catamaran™ Fixation Device which passes through both the axial and sagittal planes of the ilium and sacrum, stabilizing and transfixing the SI Joint along its longitudinal axis. The angle and trajectory of the Catamaran surgical approach is also designed to provide a pathway away from critical neural and vascular structures and into the strongest cortical bone. Since the national launch of the Catamaran SI Joint Fusion System in October 2022 Tenon is focused on two commercial opportunities with its System in the SI Joint market which includes: 1) Primary SI Joint procedures, and 2) Revision procedures of failed SI Joint implants. For more information, please visit www.tenonmed.com.\nThe Tenon Medical logo Tenon Medical, and Catamaran are registered trademarks of Tenon Medical, Inc. MAINSAIL is a trademark of Tenon Medical\nSafe Harbor\nThis press release contains \"forward-looking statements,\" which are statements related to events, results, activities, or developments that Tenon expects, believes, or anticipates will or may occur in the future. Forward-looking often contains words such as \"intends,\" \"estimates,\" \"anticipates,\" \"hopes,\" \"projects,\" \"plans,\" \"expects,\" \"seek,\" \"believes,\" \"see,\" \"should,\" \"will,\" \"would,\" \"target,\" \"aims,\" and similar expressions and the negative versions thereof. Such statements are based on Tenon's experience and perception of current conditions, trends, expected future developments and other factors it believes are appropriate under the circumstances, and speak only as of the date made. Forward-looking statements are inherently uncertain and actual results may differ materially from assumptions, estimates or expectations reflected or contained in the forward-looking statements as a result of various factors. For details on the uncertainties that may cause our actual results to be materially different than those expressed in our forward-looking statements, please review our Annual Report on 10-K on file with the Securities and Exchange Commission at www.sec.gov, particularly the information contained in the section entitled \"Risk Factors\". We undertake no obligation to publicly update or revise any forward-looking statements to reflect new information or future events or otherwise unless required by law.\nIR Contact:\nShannon Devine / Rory Rumore203-741-8811MZ North Americatenon@mzgroup.us\nSOURCE: Tenon Medical, Inc.\n\nView the original \npress release on accesswire.com","kind":null,"is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"","news_rank":0,"symbols":[],"gpt_button":0},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.29.1","shortVersion":"4.29.1","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2468687786"}